Salus Laboratories Profile
Key Indicators
- Authorised Capital ₹ 7.80 M
as on 23-12-2024
- Paid Up Capital ₹ 6.60 M
as on 23-12-2024
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.89 Cr
as on 23-12-2024
- Revenue -43.51%
(FY 2022)
- Profit -41.63%
(FY 2022)
- Ebitda -60.71%
(FY 2022)
- Net Worth 15.98%
(FY 2022)
- Total Assets 13.94%
(FY 2022)
About Salus Laboratories
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.80 M and a paid-up capital of Rs 6.60 M.
The company has closed loans amounting to ₹1.89 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Adinarayana Kamma and Rajasekhar Tammineedi serve as directors at the Company.
- CIN/LLPIN
U24239TG2004PTC042674
- Company No.
042674
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Salus Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Adinarayana Kamma  | Director | 25-Feb-2007 | Current |
| Rajasekhar Tammineedi | Director | 18-Feb-2004 | Current |
Financial Performance of Salus Laboratories.
Salus Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 43.51% decrease. The company also saw a substantial fall in profitability, with a 41.63% decrease in profit. The company's net worth Soared by an impressive increase of 15.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Salus Laboratories?
In 2021, Salus Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 24 Aug 2022 | ₹2.00 M | Satisfied |
Bank Of India Creation Date: 20 Jul 2022 | ₹6.90 M | Satisfied |
A.P. State Finnacial Corporation Creation Date: 18 Mar 2005 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Salus Laboratories?
Salus Laboratories has a workforce of 23 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Salus Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salus Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
